Amid a challenging retail landscape, Target Corporation (TGT) is drawing attention from value investors who argue its depressed stock price and reliable dividend profile present a compelling opportunity for steady returns.
Stride, Inc., a leading provider of K-12 online education, has seen its stock price pressured by temporary operational challenges. However, a closer look reveals a fundamentally sound business trading at a significant discount to its historical valuation, with a robust recurring revenue model and a substantial share buyback program underway.
Investment firm Kiker Wealth Management has significantly reduced its holdings in the Invesco PDBC ETF, part of a sweeping divestment that slashed its total assets from $198 million to just $3 million by year-end 2025.
Walmart stock jumped over 4% Monday as a new trade agreement between the U.S. and India promises lower tariffs and increased market access, bolstering the retail giant's strategic pivot toward Indian manufacturing and e-commerce.
Once a high-flying adtech darling, The Trade Desk has seen its stock crater nearly 80% from its peak amid a fierce battle with Amazon's ad juggernaut. With shares now trading at a significant discount to the market, analysts are divided on whether this marks a historic buying opportunity or signals deeper structural challenges.
Investors seeking stability in volatile markets often turn to consumer staples ETFs. We analyze the strategic divergence between Fidelity's broad, low-cost approach and Invesco's targeted, factor-driven fund to determine which might better serve a defensive portfolio.
At a high-profile industry gathering in Taipei, Nvidia CEO Jensen Huang highlighted the intense demand for advanced semiconductors, calling on TSMC to accelerate output as AI hardware needs strain global supply chains.
In an exclusive interview, GeneDx CEO Katherine Stueland details how rapid genomic testing is transforming pediatric care, slashing diagnosis times from years to days and building a data-driven bridge to future therapies.
Palantir Technologies' fourth-quarter earnings reveal a seismic shift, with U.S. commercial revenue for its AI Platform soaring 137%. The data analytics firm posted its highest growth rate as a public company, powered by massive government contracts and enterprise adoption, while setting aggressive targets for the year ahead.
As trillions pass to heirs, inheriting property often brings complex financial obligations, from taxes to upkeep, that can erode perceived wealth gains. Experts urge careful planning to navigate the emotional and fiscal challenges.
The U.S. dollar climbed to a one-week high, buoyed by unexpectedly strong manufacturing activity and hawkish-leaning Federal Reserve commentary. The rally pressured major currency pairs and sent precious metals tumbling, as markets reassessed the timeline for potential interest rate cuts.
Kforce reports stronger-than-expected Q4 2025 results, citing the highest sequential growth in its tech business since 2022. The company sees early signs of a market recovery, fueled by client demand for flexible talent to tackle AI-driven projects and foundational IT work.
With a fortified war chest and production scaling up, Rivian is poised for its most critical test yet: winning over the mass market with its upcoming R2. While the financial runway is clear, the road to profitability hinges on consumer appetite for the new, more affordable model.
InterDigital has secured a new multi-year patent license agreement with LG Electronics, extending its royalty base into consumer electronics like digital TVs and display monitors, signaling a strategic diversification of its licensing revenue.
A recent adjustment to Ceres Power Holdings' price target by analysts signals a broader reassessment of the clean energy firm's market narrative and future trajectory, moving beyond a single figure to underlying story shifts.
Identity management giant Okta is responding to a significant phishing campaign targeting over 100 enterprise customers' single sign-on credentials, while simultaneously naming Dan Mountstephen to lead its Asia-Pacific and Japan expansion efforts.
Merck & Co. is laying the groundwork for its future in oncology beyond Keytruda, announcing a strategic investment in biotech Eikon Therapeutics and a major collaboration with diagnostic leader Guardant Health. The moves signal a targeted, partnership-driven strategy to bolster its pipeline and diagnostics capabilities in the competitive cancer therapy market.
A new federally-backed investment vehicle for minors, dubbed 'Trump Accounts,' launches next month. Children born through 2028 could receive a $1,000 government contribution, with financial experts highlighting its potential to build a significant nest egg for education and retirement.
Gold and silver prices have soared over the past year, but recent volatility has many consumers and investors weighing whether to cash in on jewelry holdings or hold firm.
Crude oil and gasoline futures tumbled sharply on Monday, pressured by a rallying U.S. dollar and signs of diplomatic engagement between the U.S. and Iran. The sell-off marks a significant reversal from last week's geopolitical premium.
